Nonetheless, anti-PD-1 blockade often promotes the accumulation of highly suppressive eTreg cells in the TME, thereby limiting ICB efficacy and promoting tumor growth [43, 130, 131]. This evidence concerns the gene PDCD1 and neoplasm.